Sponsor study identifier
interventional
100
1 country
1
Study Start
August 20, 2024
Actual (reported)Primary Completion
March 20, 2025
Actual (reported)Study Completion
March 20, 2025
Actual (reported)This randomized, single-blind, placebo-controlled clinical trial aims to evaluate the effect of an experimental gel based on Acmella oleracea (jambú) extract, associated or not with fluoride, in reducing dentin hypersensitivity (DH) in non-carious cervical lesions. The volunteers were randomized into 4 groups according to the treatments applied: CT (control), NP (potassium nitrate), AO (Acmella oleracea) and AF (Acmella oleracea associated with fluoride). Prophylaxis with pumice stone and water was performed on the previously selected teeth and, subsequently, the gels were applied to the cervical region with a microbrush, rubbed for 10 seconds, and remained on the tooth surface for 10 minutes. Three gel application sessions were performed, with 1-week interval between them. The DH evaluation was performed at four time points: baseline (before the first session), T1 (before the second session), T2 (before the third session) and T3, one week after the final application of the products.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 20, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 20, 2024
Actual (reported)March 20, 2025
Actual (reported)March 20, 2025
Actual (reported)May 6, 2025
Actual (reported)May 14, 2025
Actual (reported)sensitivity assessment
Dentin hypersensitivity (DH) will be assessed at four time points: baseline (immediately before the first session), T1 (immediately before the second session), T2 (immediately before the third session), and T3 (one week after the final application of the products). DH will be evaluated using the Visual Analog Scale (VAS). This scale consists of a 10 cm horizontal line with scores of 0 and 10 at each end, where 0 indicates no sensitivity and 10 indicates severe dental sensitivity. Patients will be instructed to draw a vertical line along the horizontal scale to indicate the intensity of their dental sensitivity on the day of assessment.The distance from the zero end to the patient's mark will be measured using a millimeter ruler. These data will be recorded and tabulated for subsequent analysis.
30 days
the group will receive the application of gel without active ingredient
the group will receive the application of gel containing potassium nitrate
the group will receive the application of gel containing Acmella Oleracea Extract Gel
will receive the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.
The gels will be applied to the sensitive lesions according to the experimental group and will be rubbed for 20 seconds using a microbrush, remaining on the lesions for 10 minutes.
Universidade Federal Do Para
Belém, Pará, Brazil
Cecy M Silva
universidade federal do pará
100 participants (actual enrollment reported by the registry).
First Submitted
May 6, 2025
First Posted
May 14, 2025
Study Start
August 20, 2024
Actual (reported)Photobiomodulation Before or After Tooth Whitening
Effect of Nano-hydroxyapatite and LASER on Dentin Hypersensitivity
the group will receive the application of gel containing Acmella Oleracea Extract Gel associated with fluoride
The Acmella oleracea gel will be applied to sensitive lesions and rubbed for 20 seconds with the aid of a microbrush, remaining on the lesions for 10 minutes.
The Acmella oleracea gel associated with fluoride will be applied to sensitive lesions and rubbed for 20 seconds with the aid of a microbrush, remaining on the lesions for 10 minutes.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
March 20, 2025
Actual (reported)Study Completion
March 20, 2025
Actual (reported)Last Updated
May 21, 2025
Record last verified: 2025-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: